Evidence map›Paper›PMID 27302061›Full record

ArticleThe Journal of biological chemistry2016

Induction of Lumen Formation in a Three-dimensional Model of Mammary Morphogenesis by Transcriptional Regulator ID4: ROLE OF CaMK2D IN THE EPIGENETIC REGULATION OF ID4 GENE EXPRESSION.

Tung Nguyen, John E Shively

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Tung NguyenFrom the Department of Immunology, Beckman Research Institute of City of Hope, Duarte, California 91010.
John E ShivelyFrom the Department of Immunology, Beckman Research Institute of City of Hope, Duarte, California 91010 jshively@coh.org.
Beckman Research InstituteCity of Hope · US

Funding

Role of CEACAM1 in Epithelial Cell PolarizationR01CA084202 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI SHIVELY, JOHN ERNEST · 2000 to 2010
$4.1M
NCI NIH HHS R01 CA084202
6 · The paper itself

Abstract

Concomitant loss of lumen formation and cell adhesion protein CEACAM1 is a hallmark feature of breast cancer. In a three-dimensional culture model, transfection of CEACAM1 into MCF7 breast cells can restore lumen formation by an unknown mechanism. ID4, a transcriptional regulator lacking a DNA binding domain, is highly up-regulated in CEACAM1-transfected MCF7 cells, and when down-regulated with RNAi, abrogates lumen formation. Conversely, when MCF7 cells, which fail to form lumena in a three-dimensional culture, are transfected with ID4, lumen formation is restored, demonstrating that ID4 may substitute for CEACAM1. After showing the ID4 promoter is hypermethylated in MCF7 cells but hypomethylated in MCF/CEACAM1 cells, ID4 expression was induced in MCF7 cells by agents affecting chromatin remodeling and methylation. Mechanistically, CaMK2D was up-regulated in CEACAM1-transfected cells, effecting phosphorylation of HDAC4 and its sequestration in the cytoplasm by the adaptor protein 14-3-3. CaMK2D also phosphorylates CEACAM1 on its cytoplasmic domain and mutation of these phosphorylation sites abrogates lumen formation. Thus, CEACAM1 is able to maintain the active transcription of ID4 by an epigenetic mechanism involving HDAC4 and CaMK2D, and the same kinase enables lumen formation by CEACAM1. Because ID4 can replace CEACAM1 in parental MCF7 cells, it must act downstream from CEACAM1 by inhibiting the activity of other transcription factors that would otherwise prevent lumen formation. This overall mechanism may be operative in other cancers, such as colon and prostate, where the down-regulation of CEACAM1 is observed.

Indexed as

Epigenesis, GeneticMorphogenesisAntigens, CDCalcium-Calmodulin-Dependent Protein Kinase Type 2Cell Adhesion MoleculesFemaleHistone DeacetylasesHumansInhibitor of Differentiation ProteinsMammary Glands, HumanMCF-7 CellsRepressor ProteinsAntigens, CDCalcium-Calmodulin-Dependent Protein Kinase Type 2CAMK2D protein, humanCD66 antigensCell Adhesion MoleculesHDAC4 protein, humanHistone DeacetylasesID4 protein, humanInhibitor of Differentiation ProteinsRepressor Proteinsbreast cancerCa2+/calmodulin-dependent protein kinase II (CaMKII)CEACAM1cell adhesionID4mammary glandRNA interference (RNAi)

Identifiers

PMID27302061
PMCPMC4974389
OpenAlexW2442389477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.